07 July 2022
Consultation is now open on our draft guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids, and our draft guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.
The guideline offers systematic and evidence-based recommendations to support UK clinicians involved in managing patients with rheumatic disease who are (or are planning to become) pregnant and/or breastfeeding, men planning to conceive, and patients who have unintentionally conceived while taking these medications.
The consultation period closes at 23:59 on Sunday 31 July.
To submit comments, please email the relevant consultation form to guidelines@rheumatology.org.uk.
Immunomodulatory anti-rheumatic drugs and corticosteroids
Draft guideline
Consultation form
Comorbidity medications used in rheumatology practice
Draft guideline
Consultation form